- Report
- July 2023
- 335 Pages
Latin America
From €8551EUR$8,995USD£7,184GBP
- Report
- March 2023
- 251 Pages
United States
From €7600EUR$7,995USD£6,385GBP
- Report
- December 2022
- 105 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- December 2022
- 421 Pages
Global
From €9502EUR$9,995USD£7,982GBP
- Report
- January 2021
South Korea
From €7600EUR$7,995USD£6,385GBP
- Report
- March 2020
China
From €7600EUR$7,995USD£6,385GBP
- Report
- January 2025
- 89 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 87 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- July 2024
- 260 Pages
Global
From €2524EUR$2,655USD£2,120GBP
The Demineralized Bone Matrix (DBM) market is a subset of the larger biomaterials industry. DBM is a type of bone graft material that is used to repair and regenerate bone tissue. It is composed of collagen and other proteins, and is processed to remove the mineral content. DBM is used in a variety of orthopedic and dental procedures, including spinal fusion, fracture repair, and dental implantation. It is also used in reconstructive surgery, such as facial reconstruction.
DBM is a growing market, with increasing demand for its use in a variety of medical procedures. It is a cost-effective alternative to autografts, and is gaining popularity due to its biocompatibility and ability to promote bone regeneration.
Some companies in the DBM market include Zimmer Biomet, Medtronic, Stryker, and Orthofix. Show Less Read more